The rise of Viagra initially sparked a boom for major pharmaceutical companies, however recent changes present a complicated outlook for those considering a stake. Off-patent alternatives are eroding profits, and https://geraldxuar973373.csublogs.com/49049969/the-blue-pill-and-pharma-a-volatile-investment